Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences
Domenico Sergi, Justine Renaud, Nicola Simola, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction
Domenico Sergi, Hakim Boulestin, Fiona Campbell, et al.
Molecular Nutrition & Food Research (2020) Vol. 65, Iss. 1
Open Access | Times Cited: 142
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Leszek Szablewski
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 542-542
Open Access | Times Cited: 2
Brain insulin resistance: role in neurodegenerative disease and potential for targeting
Christian Hölscher
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 4, pp. 333-348
Open Access | Times Cited: 135
Protective properties of GLP‐1 and associated peptide hormones in neurodegenerative disorders
Christian Hölscher
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 695-714
Open Access | Times Cited: 95
Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction
Francesca Chiara Pignalosa, Antonella Desiderio, Paola Mirra, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12366-12366
Open Access | Times Cited: 75
Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit
Gesine Paul, Osama F. Elabi
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 49
Metabolic Syndrome, Cognitive Impairment and the Role of Diet: A Narrative Review
Matina Kouvari, Nathan M. D’Cunha, Nikolaj Travica, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 333-333
Open Access | Times Cited: 46
HOMA-IR and TyG index differ for their relationship with dietary, anthropometric, inflammatory factors and capacity to predict cardiovascular risk
Domenico Sergi, Riccardo Spaggiari, Edoardo Dalla Nora, et al.
Diabetes Research and Clinical Practice (2025), pp. 112103-112103
Open Access | Times Cited: 1
Diabetes Mellitus and Parkinson's Disease: Shared Pathophysiological Links and Possible Therapeutic Implications
Abdallah Hassan, Rajan Sharma Kandel, Rohi Mishra, et al.
Cureus (2020)
Open Access | Times Cited: 62
Proteomics Analysis of Gastric Cancer Patients with Diabetes Mellitus
Hugo Osório, Cátia Silva, Marta Ferreira, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 407-407
Open Access | Times Cited: 48
The role of NURR1 in metabolic abnormalities of Parkinson’s disease
Murad Al‐Nusaif, Yuting Yang, Song Li, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 31
Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones
Susana Cardoso, Paula I. Moreira
International review of neurobiology (2020), pp. 37-64
Closed Access | Times Cited: 45
Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease—Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors
Kai-Jung Lin, Tzu‐Jou Wang, Shang‐Der Chen, et al.
Antioxidants (2021) Vol. 10, Iss. 12, pp. 1935-1935
Open Access | Times Cited: 39
High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease
Osama F. Elabi, João Paulo Monteiro Carvalho Móri da Cunha, Abderahim Gaceb, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 38
Synergistic Effects of Milk-Derived Exosomes and Galactose on α-Synuclein Pathology in Parkinson’s Disease and Type 2 Diabetes Mellitus
Bodo C. Melnik
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1059-1059
Open Access | Times Cited: 36
Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson’s disease
Xiaoyan Yang, Peng Feng, Rong Ji, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 5, pp. 445-460
Closed Access | Times Cited: 27
The Interplay between Ghrelin and Microglia in Neuroinflammation: Implications for Obesity and Neurodegenerative Diseases
Cristina Russo, Maria Stella Valle, Antonella Russo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13432-13432
Open Access | Times Cited: 24
Islet amyloid polypeptide triggers α-synuclein pathology in Parkinson’s disease
Lanxia Meng, Yiming Li, Congcong Liu, et al.
Progress in Neurobiology (2023) Vol. 226, pp. 102462-102462
Closed Access | Times Cited: 13
Down-regulation of platelet-derived growth factor receptor β in pericytes increases blood-brain barrier permeability and significantly enhances α-synuclein in a Parkinson’s Disease 3D cell model in vitro under hyperglycemic condition
Ting Wang, Mengyan Li, Zhong Pei, et al.
Tissue and Cell (2025) Vol. 93, pp. 102751-102751
Closed Access
Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson’s disease
Sohyun Jeong, Hyemin Cho, Yun Joong Kim, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0247354-e0247354
Open Access | Times Cited: 32
Palmitic Acid, but Not Lauric Acid, Induces Metabolic Inflammation, Mitochondrial Fragmentation, and a Drop in Mitochondrial Membrane Potential in Human Primary Myotubes
Domenico Sergi, Natalie D. Luscombe‐Marsh, Nenad Naumovski, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 30
Communal interaction of glycation and gut microbes in diabetes mellitus, Alzheimer's disease, and Parkinson's disease pathogenesis
Rahul Patil, Rashmi S. Tupe
Medicinal Research Reviews (2023) Vol. 44, Iss. 1, pp. 365-405
Closed Access | Times Cited: 12
Assessing the Safety and Therapeutic Efficacy of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson’s Rats
Sarawut Lapmanee, Sakkarin Bhubhanil, Prapimpun Wongchitrat, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 514-514
Open Access | Times Cited: 4
Parkinson’s disease and metabolic disorders, understanding their shared co-morbidity through the autonomic nervous system
Thanh Pham, Rebecca E. Schelling, Ken H. Loh
Advances in genetics (2025)
Closed Access
Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson’s Disease Mouse Model
Zijuan Zhang, Hai Li, Yunfang Su, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top